Group 4 - Hemorrhagic Stroke
Group 4 - Hemorrhagic Stroke
Group 4 - Hemorrhagic Stroke
OBJECTIVES
• HEMORRHAGIC STROKE
• Hemorrhagic stroke results from weakened vessel that ruptures and bleeds
into the surrounding brain parenchyma
• Intracranial Hemorrhage
• the hemorrhage is into the substance or parenchyma of the brain
• Subarachnoid Hemorrhage
• bleeding originates in the subarachnoid spaces surrounding the brain and the
ventricular system
HEMORRHAGIC STROKE
STAGES
• COMMON SITES
• (1) the putamen and adjacent internal capsule (Putaminal Hemorrhage)
• (2) the central white matter of the temporal, parietal, or frontal lobes (Lobar
Hemorrhage - not strictly associated with hypertension)
• (2) at the origin of the posterior communicating artery from the stem of the
internal carotid
• (4) at the bifurcation of the internal carotid into middle and anterior cerebral
arteries
SPONTANEOUS SUBARACHNOID
HEMORRHAGE
PATHOPHYSIOLOGY
• Secondary Brain Injury and edema develops for the 1st 24-96 hrs and
slowly resolves over several weeks
PATHOPHYSIOLOGY
Chronic Hypertension
+
Degenerative
Changes
Charcot-
Bouchard
Aneurysm
ICH
SIGNS AND SYMPTOMS
SIGNS & symptoms
• ICH
• Almost occur while px is awake
• Abrupt onset of focal neurological deficit
• Diminished LOC
• Signs of Increased ICP
• ICH
• Pontine Hemorrhage- deep coma with quadriplegia, pinpoint pupils,
decerebrate rigidity , hyperhydrosis, Severe Hypertension, impaired
horizontal eyemovements
• SAH
• Signs may depend on the site of bleed
• ICH
• NeuroImaging
• CT scan----Method of choice to evaluate the
presence of ICH. Evaluates:
• size
• location of the hematoma
• extension into the ventricular system
• degree of surrounding edema
• anatomic disruption
• Hematoma volume (predictor of 30-day
mortality) calculation from CT scan images:
diagnostics
diagnostics
• Others :
• CBC
• Glucose - higher serum glucose is associated with worse outcome
• PT (with INR) - warfarin-related hemorrhages are associated with an
increased hematoma volume, greater risk of expansion, and increased
morbidity and mortality
• Toxicoloy screen- to detect cocaine and other sympathomimetic drugs of
abuse which are asociated with ICH.
diagnostics
• Neurodiagnostic examination
• Four vessel
angiogram is
mandatory when CT
and MRA is negative.
management
management
• ICH
• Stabilize vital signs -adequate ventilation
• Monitoring and control of intracranial pressure-
Mannitol
• Acute hypertension-beta blocking
agents(esmolol, labetalol)
• Diuretics
• Drain-acute hydrocephalus
• Surgical Evacuation of cerebral hematoma
• >4 cm or more in largest diameter, esp in the
vermis
management
• ICH
• Anticoagulation leads to more hematoma growth
and higher mortality
• Reverse warfarin promptly and aggressively
• FFP or prothrombin complex concentrates
(PCCs)
• IV vitamin K
• Faster than SQ/PO but a small risk of
anaphylactoid reaction
SURGICAL MANAGEMENT
• Treating hydrocephalus
-Temporary ventricular drainage
• Treating hyponatremia
-supplemental oral salts coupled with normal
saline
-Intravenous hypertonic saline
• Limiting secondary brain insults
• Preventing pulmonary embolism
-pneumatic compression stockings
-Unfractionated heparin
prognosis
RISK FACTORS
•Lobar ICH
•Older age
•Anticoagulation
•Apo E e2 or e4 alleles
•Increased number of “microbleeds” on MRI
RISK FACTORS
•REBLEEDING
•Fever
•Cerebral Ischemia
•Non obliterated aneurysms
prognosis
Neurons Brain Synapses Axons Accelerated
Lost Cells Lost Lost Lost Aging
Per Hour 58 million 1.2 billion 420 billion 247 miles 2 years
• Joint contractures
• Muscle spasticity